Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Study results from University of Colorado broaden understanding of breast cancer
February 5th, 2009
"This transcript is based on my The Year in Basic Science lecture at ENDO 2008. I reviewed current data surrounding hormone replacement therapy and the relationship between systemic estrogen plus progestin (E + P) treatment and increased breast cancer risk, and I explored the hypothesis that women who develop breast cancer while on E + P had occult, undiagnosed disease before they started therapy," scientists writing in the journal Molecular Endocrinology report. "Beginning with recent hormone replacement therapy data focusing on E + P and its association with breast cancer to set the stage, the lecture then reviewed our newly published data that progestins...
Source: Women's Health Weekly (2009-02-05)
|
